Rolziracetam
|
R694394-5mg
|
≥99% |
18356-28-0 |
5mg
|
¥ 1976.9
|
期货,请咨询 |
阿拉丁 |
Rolziracetam
|
R694394-10mg
|
≥99% |
18356-28-0 |
10mg
|
¥ 3073.9
|
期货,请咨询 |
阿拉丁 |
替诺福韦-D7
|
R694105-1mg
|
|
107021-12-5 |
1mg
|
¥ 14075.9
|
期货,请咨询 |
阿拉丁 |
Ropitoin
|
R694003-5mg
|
≥98% |
56079-81-3 |
5mg
|
¥ 11116.9
|
期货,请咨询 |
阿拉丁 |
Ropitoin
|
R694003-1mg
|
≥98% |
56079-81-3 |
1mg
|
¥ 5280.9
|
期货,请咨询 |
阿拉丁 |
芸香内酯
|
R693857-5mg
|
≥98% |
14882-94-1 |
5mg
|
¥ 4906.9
|
期货,请咨询 |
阿拉丁 |
连翘环己醇
|
R692432-5mg
|
≥97% |
93675-85-5 |
5mg
|
¥ 2223.9
|
期货,请咨询 |
阿拉丁 |
Ricinelaidic Acid
|
R691085-100mg
|
≥98% |
540-12-5 |
100mg
|
¥ 3729.9
|
期货,请咨询 |
阿拉丁 |
顺式-6-苄基八氢-1H-吡咯并[3,4-b]吡啶
|
R690861-250mg
|
≥95% |
161594-54-3 |
250mg
|
¥ 3991.9
|
期货,请咨询 |
阿拉丁 |
顺式-6-苄基八氢-1H-吡咯并[3,4-b]吡啶
|
R690861-1g
|
≥95% |
161594-54-3 |
1g
|
¥ 7984.9
|
期货,请咨询 |
阿拉丁 |
rel-(2S,4R)-1-(叔丁氧基羰基)-4-氟吡咯烷-2-羧酸
|
R690543-5g
|
≥98% |
2085759-54-0 |
5g
|
¥ 925.9
|
期货,请咨询 |
阿拉丁 |
rel-(2S,4R)-1-(叔丁氧基羰基)-4-氟吡咯烷-2-羧酸
|
R690543-25g
|
≥98% |
2085759-54-0 |
25g
|
¥ 3146.9
|
期货,请咨询 |
阿拉丁 |
rel-(2S,4R)-1-(叔丁氧基羰基)-4-氟吡咯烷-2-羧酸
|
R690543-1g
|
≥98% |
2085759-54-0 |
1g
|
¥ 265.9
|
期货,请咨询 |
阿拉丁 |
(2R,3R)-REL-2,3-丁二醇
|
R690454-100mg
|
≥98% |
6982-25-8 |
100mg
|
¥ 284.9
|
期货,请咨询 |
阿拉丁 |
2-(甲硫基)喹啉
|
Q736340-250mg
|
≥97% |
40279-26-3 |
250mg
|
¥ 2551.9
|
期货,请咨询 |
阿拉丁 |
2-(甲硫基)喹啉
|
Q736340-1g
|
≥97% |
40279-26-3 |
1g
|
¥ 6890.9
|
期货,请咨询 |
阿拉丁 |
2-(甲硫基)喹啉
|
Q736340-100mg
|
≥97% |
40279-26-3 |
100mg
|
¥ 1276.9
|
期货,请咨询 |
阿拉丁 |
喹啉-7-基甲醇
|
Q736050-250mg
|
≥95% |
39982-49-5 |
250mg
|
¥ 2593.9
|
期货,请咨询 |
阿拉丁 |
喹啉-7-基甲醇
|
Q736050-1g
|
≥95% |
39982-49-5 |
1g
|
¥ 8297.9
|
期货,请咨询 |
阿拉丁 |
喹啉-7-基甲醇
|
Q736050-100mg
|
≥95% |
39982-49-5 |
100mg
|
¥ 1235.9
|
期货,请咨询 |
阿拉丁 |
2-(邻甲苯基)喹啉-4-羧酸
|
Q735497-5g
|
≥95% |
174636-85-2 |
5g
|
¥ 5460.9
|
期货,请咨询 |
阿拉丁 |
2-(邻甲苯基)喹啉-4-羧酸
|
Q735497-250mg
|
≥95% |
174636-85-2 |
250mg
|
¥ 578.9
|
期货,请咨询 |
阿拉丁 |
2-(邻甲苯基)喹啉-4-羧酸
|
Q735497-1g
|
≥95% |
174636-85-2 |
1g
|
¥ 1560.9
|
期货,请咨询 |
阿拉丁 |
3-(三氟甲基)喹喔啉-2(1H)-酮
|
Q735342-250mg
|
≥98% |
58457-64-0 |
250mg
|
¥ 1125.9
|
期货,请咨询 |
阿拉丁 |